Home › NDC Lookup › RxCUI directory › RxCUI 401978

Sumatriptan 10 MG/ACTUAT Nasal Spray — RxCUI 401978

RxNorm drug concept · Semantic clinical drug
RxCUI 401978 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI401978
Official nameSumatriptan 10 MG/ACTUAT Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assumatriptan 10 MG/Spray Nasal Spray
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)428 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sumatriptan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sumatriptan is specifically for migraine headaches — it's not a general pain reliever like ibuprofen. It's designed to stop a migraine attack once it's already started, with or wit...
  • What exactly is sumatriptan for? Will it work on any headache?
  • You don't need to wait until it's unbearable. Taking sumatriptan at the first sign of a migraine is generally the right move — don't wait it out. That said, it is meant for confirm...
  • When should I take sumatriptan — do I have to wait until the headache is severe?
📖 Read our full Sumatriptan guide →

🕸️ Concept Web — How Sumatriptan 10 MG/ACTUAT Nasal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sumatriptan 10 MG/ACTUAT Nasal Spray RxCUI 401978

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sumatriptan 37418
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tosymra 2178068
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sumatriptan Nasal Spray 379118
    • Sumatriptan Inhalant Product 1163609
    • Sumatriptan Nasal Product 1163611
    • Sumatriptan Nasal Spray [Tosymra] 2178070
    • Tosymra Inhalant Product 2178071
    • Tosymra Nasal Product 2178072
    • Nasal Spray 126542
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sumatriptan 10 MG/ACTUAT SCDC · 402412
  • Sumatriptan Nasal Spray SCDF · 379118
  • Sumatriptan Inhalant Product SCDG · 1163609
  • Sumatriptan Nasal Product SCDG · 1163611

Brand-Name Concepts

  • Sumatriptan 10 MG/ACTUAT Nasal Spray [Tosymra] SBD · 2178073
  • Sumatriptan 10 MG/ACTUAT [Tosymra] SBDC · 2178069
  • Sumatriptan Nasal Spray [Tosymra] SBDF · 2178070
  • Tosymra Inhalant Product SBDG · 2178071
  • Tosymra Nasal Product SBDG · 2178072
  • Tosymra BN · 2178068

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 401978 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00245-0812-61 6 BLISTER PACK in 1 CARTON (0245-0812-61) / 1 BOTTLE, SPRAY... TOSYMRA Upsher-Smith Laboratories, LLC 2021-09-01
70792-0812-59 1 BLISTER PACK in 1 CARTON (70792-812-59) / 1 BOTTLE, SPRAY... Tosymra Tonix Medicines, Inc. 2024-07-01
70792-0812-61 6 BLISTER PACK in 1 CARTON (70792-812-61) / 1 BOTTLE, SPRAY... Tosymra Tonix Medicines, Inc. 2024-07-01
70792-0812-89 1 BLISTER PACK in 1 CARTON (70792-812-89) / 1 BOTTLE, SPRAY... Tosymra Tonix Medicines, Inc. 2025-04-01
Observed labelers: Tonix Medicines, Inc. (3) · Upsher-Smith Laboratories, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$108.1800
Range $108.1800–$108.1800 · middle 50% $108.1800–$108.1800 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.